Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_assertion description "[Treatment of cancer cells derived from urologic (bladder and prostate) and gastrointestinal (pancreas and colon) tumors with arsenic trioxide demonstrated that these cells exhibited differential responsiveness to the antiproliferative effects of this agent and this paralleled their differential repression of Sp1, Sp3 and Sp4 proteins in the same cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_assertion evidence source_evidence_literature NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_assertion SIO_000772 20435036 NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_assertion wasDerivedFrom befree-20140225 NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_assertion wasGeneratedBy ECO_0000203 NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP188821.RAHIUcplSuJhn4Jwwci0ehi7zUD4H7x6qbSWWugIYE-F4130_provenance.